UniProt ID | DHCR7_HUMAN | |
---|---|---|
UniProt AC | Q9UBM7 | |
Protein Name | 7-dehydrocholesterol reductase | |
Gene Name | DHCR7 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 475 | |
Subcellular Localization |
Endoplasmic reticulum membrane Multi-pass membrane protein . |
|
Protein Description | Production of cholesterol by reduction of C7-C8 double bond of 7-dehydrocholesterol (7-DHC).. | |
Protein Sequence | MAAKSQPNIPKAKSLDGVTNDRTASQGQWGRAWEVDWFSLASVIFLLLFAPFIVYYFIMACDQYSCALTGPVVDIVTGHARLSDIWAKTPPITRKAAQLYTLWVTFQVLLYTSLPDFCHKFLPGYVGGIQEGAVTPAGVVNKYQINGLQAWLLTHLLWFANAHLLSWFSPTIIFDNWIPLLWCANILGYAVSTFAMVKGYFFPTSARDCKFTGNFFYNYMMGIEFNPRIGKWFDFKLFFNGRPGIVAWTLINLSFAAKQRELHSHVTNAMVLVNVLQAIYVIDFFWNETWYLKTIDICHDHFGWYLGWGDCVWLPYLYTLQGLYLVYHPVQLSTPHAVGVLLLGLVGYYIFRVANHQKDLFRRTDGRCLIWGRKPKVIECSYTSADGQRHHSKLLVSGFWGVARHFNYVGDLMGSLAYCLACGGGHLLPYFYIIYMAILLTHRCLRDEHRCASKYGRDWERYTAAVPYRLLPGIF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Ubiquitination | ----MAAKSQPNIPK ----CCCCCCCCCCC | 39.83 | - | |
5 | Phosphorylation | ---MAAKSQPNIPKA ---CCCCCCCCCCCC | 46.25 | 24719451 | |
13 | Ubiquitination | QPNIPKAKSLDGVTN CCCCCCCCCCCCCCC | 58.64 | 21890473 | |
14 | Phosphorylation | PNIPKAKSLDGVTND CCCCCCCCCCCCCCC | 36.23 | 29255136 | |
19 | Phosphorylation | AKSLDGVTNDRTASQ CCCCCCCCCCCCCCC | 36.61 | 23927012 | |
23 | Phosphorylation | DGVTNDRTASQGQWG CCCCCCCCCCCCCCC | 33.26 | 23090842 | |
25 | Phosphorylation | VTNDRTASQGQWGRA CCCCCCCCCCCCCCC | 33.94 | 23090842 | |
88 | Ubiquitination | RLSDIWAKTPPITRK EHHHHHHHCCCCCHH | 46.71 | 21890473 | |
88 | Ubiquitination | RLSDIWAKTPPITRK EHHHHHHHCCCCCHH | 46.71 | 21890473 | |
135 | Phosphorylation | GIQEGAVTPAGVVNK CCCCCCCCCCCCCCC | 13.59 | - | |
205 | Phosphorylation | KGYFFPTSARDCKFT CCEECCCCHHCCEEE | 22.88 | - | |
231 | Ubiquitination | EFNPRIGKWFDFKLF EECCCCCCEEEEEEE | 42.17 | 21890473 | |
254 | Phosphorylation | AWTLINLSFAAKQRE HHHHHHHHHHHHHHH | 14.35 | 27174698 | |
358 | Ubiquitination | FRVANHQKDLFRRTD HHHHHCCHHHHHCCC | 49.17 | 21890473 | |
358 | Ubiquitination | FRVANHQKDLFRRTD HHHHHCCHHHHHCCC | 49.17 | 21890473 | |
374 | Ubiquitination | RCLIWGRKPKVIECS CEEEECCCCCEEEEE | 45.30 | - | |
376 | Ubiquitination | LIWGRKPKVIECSYT EEECCCCCEEEEEEE | 59.90 | - | |
381 | Phosphorylation | KPKVIECSYTSADGQ CCCEEEEEEECCCCC | 20.75 | 28152594 | |
382 | Phosphorylation | PKVIECSYTSADGQR CCEEEEEEECCCCCC | 19.17 | 28152594 | |
383 | Phosphorylation | KVIECSYTSADGQRH CEEEEEEECCCCCCH | 10.93 | 28152594 | |
384 | Phosphorylation | VIECSYTSADGQRHH EEEEEEECCCCCCHH | 19.01 | 28152594 | |
397 | Phosphorylation | HHSKLLVSGFWGVAR HHHHHHHHCHHHHHH | 28.39 | - | |
453 | Phosphorylation | RDEHRCASKYGRDWE HCCCCHHHHHCCCHH | 30.00 | 30387612 | |
454 | Ubiquitination | DEHRCASKYGRDWER CCCCHHHHHCCCHHH | 32.95 | 21890473 | |
454 | Acetylation | DEHRCASKYGRDWER CCCCHHHHHCCCHHH | 32.95 | 25953088 | |
455 | Phosphorylation | EHRCASKYGRDWERY CCCHHHHHCCCHHHH | 18.20 | 30387612 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DHCR7_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DHCR7_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DHCR7_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of DHCR7_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00161 | Smith-Lemli-Opitz syndrome | |||||
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action), including: Congenita | |||||
OMIM Disease | ||||||
270400 | Smith-Lemli-Opitz syndrome (SLOS) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14, AND MASSSPECTROMETRY. |